BACK TO TOP
KSE100
177,873.87
500.11
(0.28%)
KSE100PR
52,566.53
147.80
(0.28%)
ALLSHR
106,712.06
589.19
(0.56%)
KSE30
51,887.20
152.18
(0.29%)
KMI30
255,042.46
1169.47
(0.46%)
BKTI
48,733.26
-108.13
(-0.22%)
OGTI
36,043.05
947.36
(2.70%)
KMIALLSHR
69,162.84
584.42
(0.85%)
PSXDIV20
81,241.03
62.40
(0.08%)
UPP9
63,867.23
-168.62
(-0.26%)
NITPGI
47,830.73
216.04
(0.45%)
NBPPGI
51,231.99
224.18
(0.44%)
MZNPI
32,045.14
216.65
(0.68%)
JSMFI
40,289.33
14.32
(0.04%)
ACI
22,910.05
-7.99
(-0.03%)
JSGBKTI
75,546.44
-41.21
(-0.05%)
HBLTTI
19,378.70
12-11-2026
0.11
(0.00%)
MII30
23,190.50
118.03
(0.51%)
Highnoon Laboratories Limited
PHARMACEUTICALS
Rs.959.62
3.50
(0.37%)
1D
1M
6M
YTD
1Y
3Y
5Y
^ As of Fri, Nov 13, 2026 4:40 PM
REG
DFC
CSF
ODL
Open
957.00
High
966.00
Low
930.00
Volume
17,255
CIRCUIT BREAKER
860.51 — 1,051.73
DAY RANGE
930.00 — 966.00
52-WEEK RANGE ^
755.56 — 1,140.00
Ask Price
0.00
Ask Volume
0
Bid Price
0.00
Bid Volume
0
LDCP
956.12
VAR
13.00
HAIRCUT
25.00
P/E Ratio (TTM) **
12.36
1-Year Change * ^
-14.81%
YTD Change * ^
-6.15%

No record found

No record found

No record found

Market data powered by capitalstake.com. Provided by PSX. ** Based on unconsolidated financials
  * Returns not adjusted for payouts
  ^The historical stock prices have been adjusted to reflect stock splits to ensure comparability over time.

Company Profile

BUSINESS DESCRIPTION

Highnoon Laboratories Limited (“the Company”) was incorporated in Pakistan under the repealed Companies Ordinance 1984 (now Companies Act, 2017) (“the Act”) and its shares are quoted on Pakistan Stock Exchange since November 1994. The Company is principally engaged in the manufacture, import, sale and marketing of pharmaceutical and related consumer products.

KEY PEOPLE
Dr. Adeel Abbas HaideriCEO
Tariq WajidChairperson
Baqar HasanCompany Secretary
ADDRESS

17.5 Kilometer Multan Road, Lahore

WEBSITE

www.highnoon-labs.com

REGISTRAR

Corplink (Pvt.) Ltd. Wings Arcade, 1-K Commercial, Model Town, Lahore.

AUDITOR

M/s BDO Ebrahim & Co. Chartered Accountants

Fiscal Year End

December

Equity Profile

Market Cap (000's)
50,843,899.60
Shares
52,983,368
Face Value
10.00
Free Float
21,193,345
Free Float
40.00%

Announcements

Financial Results
Board Meetings
Others
DateTitleDocument
Oct 30, 2026Transmission of Quarterly Report for the Period Ended September 30, 2026 View   PDF
Oct 27, 2026Financial Results for the Quarter Ended View   PDF
Aug 28, 2026Transmission of Quarterly Report for the Period Ended 30.06.2026 View   PDF
Aug 27, 2026Financial Results for the Quarter Ended 30.06.2026 View   PDF
Jun 4, 2026Shariah Disclosure for the year ended December 31 2025 View   PDF
DateTitleDocument
Oct 20, 2026Board Meeting View   PDF
Aug 20, 2026Board Meeting View   PDF
Apr 30, 2026Certified Copies of Resolutions passed at the 43rd Annual General Meeting of Highnoon Laboratories Limited held on 30th April 2026 View   PDF
Apr 22, 2026Board Meeting View   PDF
Apr 8, 2026Notice of Annual General Meeting View   PDF
DateTitleDocument
Oct 19, 2026Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View   PDF
Jun 30, 2026Material Information- Shariah Screening Compliance Confirmation
REVOKED
View   PDF
Jun 12, 2026Mandatory Conversion of Physical Shares to Book-Entry Form Unclaimed Dividend (s) / Share Certificates View   PDF
May 15, 2026Credit of Final Cash Dividend View   PDF
May 5, 2026Video Recording of Corporate Briefing Session Highnoon Laboratories Limited View   PDF

Financials

All numbers in thousands (000's) except EPS

Annual
Quarterly
2025202420232022
Sales25,789,24223,195,15219,424,25515,815,937
Profit after Taxation4,119,3133,253,5012,403,0142,417,172
EPS77.7561.4145.3545.62
Q3 2026Q2 2026Q1 2026Q3 2025
Sales6,617,0165,892,8866,813,9706,575,586
Profit after Taxation943,616721,771955,6841,001,079
EPS17.8113.6218.0418.89
Data powered by Capital Stake. To provide comparable data, information might have been standardized. The data presented may therefore differ from issuer's annual report and 'as reported' data should be obtained directly from the source issuer. See the Capital Stake Terms of Use.

Ratios

2025202420232022
Gross Profit Margin (%)54.7851.4347.6450.77
Net Profit Margin (%)15.9714.0312.3715.28
EPS Growth (%)26.6135.41(0.59)5.68
PEG0.490.42(18.80)2.09

Payouts

Financial Reports